TRPC1 and cervical adenocarcinoma: The expression levels of TRPV (Olusola et al., 2019; Buskwofie et al., 2020), TRPC (Liberati et al., 2013; Olusola et al., 2019; Jimenez et al., 2020; Lefranc, 2021) and TRPM (Liberati et al., 2013; Olusola et al., 2019; Erin, 2020; Jimenez et al., 2020; Stewart, 2020) were decreased in cervical squamous cell carcinoma and cervical adenocarcinoma, with more obvious trend of TRPV1 and TRPC1, while the expression of TRPV (Stewart, 2020; Lefranc, 2021) and TRPM (Buskwofie et al., 2020; So et al., 2020) increased (Figure 1A).